Cost Per-Responder Analysis of Secukinumab Compared To Adalimumab For The Treatmenmt of Ankylosing Spondylitis Over One Year In Saudi Arabia
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.609
https://www.valueinhealthjournal.com/article/S1098-3015(18)32966-8/fulltext
Title :
Cost Per-Responder Analysis of Secukinumab Compared To Adalimumab For The Treatmenmt of Ankylosing Spondylitis Over One Year In Saudi Arabia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32966-8&doi=10.1016/j.jval.2018.07.609
First page :
Section Title :
Open access? :
No
Section Order :
526